TOPIC:PHARMA-HEALTHCARE-POLICY-REGULATION

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the revocation of the marketing authorization for Tavneos (avacopan), an Amgen-manufactured treatment for severe active …

Public Health Officials Confirm End of Hantavirus Exposure Risk for Cruise Passengers All U.S. passengers and crew members previously under medical monitoring following potential hantavirus exposure on a cruise ship …

Understanding Pharmaceutical Patent Protection: Balancing Innovation and Access The pharmaceutical industry operates on a complex foundation of intellectual property law. At the heart of this system is the patent, a …

U.S. Citizen Infected with Ebola in DRC Evacuated to Germany Amid Outbreak A U.S. Citizen has tested positive for Ebola in the Democratic Republic of Congo (DRC), marking a significant …